A 30-year-old man on multidrug-resistant tuberculosis treatment including linezolid and bedaquiline for one year presents with sudden shortness of breath, severe metabolic acidosis (pH 7.1) with lactate 20 mmol/L, low PaCO₂, high inspired O₂, and normal renal function, liver function, complete blood count, and electrolytes. What immediate management steps should be taken?

Immediately discontinue linezolid—this is life-threatening linezolid-induced lactic acidosis

This patient requires urgent discontinuation of linezolid and aggressive supportive care for severe metabolic acidosis. The presentation of sudden shortness of breath with extreme lactate elevation (20 mmol/L), severe acidosis (pH 7.1), and normal organ function after one year of linezolid therapy is pathognomonic for linezolid-induced mitochondrial toxicity 1.

Immediate Management Steps

1. Stop Linezolid Immediately

• Linezolid must be discontinued without delay 1, 2
• The FDA drug label explicitly warns about lactic acidosis with linezolid use, particularly with prolonged therapy 1
• Recovery depends on prompt drug cessation—delayed recognition is associated with mortality 3

2. Initiate Renal Replacement Therapy

• Consider urgent hemodialysis or continuous renal replacement therapy (CRRT) 2
• Approximately 30% of linezolid is removed during a 3-hour dialysis session 1
• Both linezolid and its metabolites are dialyzable, which can accelerate clearance 1
• One case report demonstrated successful resolution of extreme lactate levels (similar to this patient) with dialytic treatment 2
• Important caveat: Some evidence suggests that once severe mitochondrial damage occurs, dialysis may not fully correct lactate accumulation 4, but it remains the best available intervention

3. Aggressive Supportive Care

• Respiratory support: The low PaCO₂ indicates compensatory hyperventilation (Kussmaul breathing); prepare for potential intubation if respiratory fatigue develops
• Intravenous sodium bicarbonate: Consider for pH <7.1 to temporize while addressing the underlying cause
• Hemodynamic monitoring: Watch for cardiovascular collapse from severe acidosis
• Correct any contributing factors: Ensure adequate tissue perfusion and oxygenation

4. Modify MDR-TB Regimen

• Continue bedaquiline and other non-linezolid components of the regimen 5
• Replace linezolid with an alternative Group A or B drug based on drug susceptibility testing:
  • Consider adding a fluoroquinolone (levofloxacin/moxifloxacin) if not already included 5
  • Add clofazimine or cycloserine/terizidone from Group B 5
  • Consult with a TB specialist or consilium immediately 5

Critical Monitoring

• Serial lactate measurements: Every 4-6 hours initially until downtrending
• Arterial blood gases: Monitor pH and compensatory mechanisms
• Complete blood count: Linezolid also causes myelosuppression 1
• Clinical status: Watch for altered mental status, seizures (reported with linezolid 1), and hemodynamic instability

Why This Happened

Linezolid inhibits mitochondrial protein synthesis by blocking mitochondrial ribosomes, leading to impaired oxidative phosphorylation and subsequent lactic acidosis 1, 6. This is a dose- and duration-dependent toxicity that becomes increasingly likely after prolonged use (>28 days) 1. After one year of therapy, this patient was at extremely high risk.

Key Risk Factors Present:

• Prolonged duration (1 year vs. recommended maximum 28 days) 1
• Critically ill state (MDR-TB patients often have multiple comorbidities) 7
• The incidence of linezolid-associated lactic acidosis in ICU patients can be as high as 10.7%, with nearly half being severe or critical 7

Common Pitfall to Avoid

Do not be falsely reassured by normal renal and liver function. Linezolid-induced lactic acidosis is a mitochondrial toxicity, not hepatic or renal dysfunction 1, 6. The normal organ function tests in this case actually support the diagnosis of drug-induced mitochondrial poisoning rather than organ failure.

Additionally, metabolic alkalosis can mask the severity of linezolid-induced hyperlactatemia 4. While this patient has frank acidosis, be aware that some patients may have elevated lactate with deceptively normal pH due to compensatory mechanisms.

Prognosis

With immediate linezolid cessation and aggressive supportive care including dialysis, full recovery is possible 2, 6. However, mortality has been reported when recognition is delayed 3. The lactate should begin trending down within 24-48 hours of stopping linezolid if mitochondrial damage is reversible.

The patient must not be rechallenged with linezolid given this life-threatening reaction 1.